Keyphrases
Adenocarcinoma
6%
Alpha-1 Antitrypsin Deficiency
7%
Cigarette Smoking
8%
Confidence Interval
17%
Genetic Variants
5%
Genetic Variation
6%
Genome-wide Association Study
6%
Genotype
7%
Glioma
7%
Hazard Ratio
6%
High Risk
7%
Lung Adenocarcinoma
16%
Lung Cancer
72%
Lung Cancer Patients
17%
Lung Cancer Risk
27%
Lung Cancer Screening
8%
Lung Cancer Survival
9%
Lung Cancer Survivor
10%
Lung Tissue
5%
Mayo Clinic
12%
Never-smokers
16%
Non-small Cell Lung Cancer (NSCLC)
37%
Non-small Cell Lung Cancer Patients
8%
Odds Ratio
10%
Overall Survival
17%
Platinum-based Chemotherapy
5%
Polymorphism
9%
Pooled Analysis
7%
Prognostic Factors
5%
Quality of Life
15%
Relative Risk
5%
Risk Factors
5%
Single nucleotide Polymorphism
15%
Small Cell Lung Cancer
9%
Smokers
6%
Smoking Cessation
5%
Smoking History
5%
Tumor
14%
Medicine and Dentistry
Adenocarcinoma
11%
Cancer Diagnosis
6%
Cancer Risk
11%
Cancer Therapy
5%
Cigarette Smoking
5%
Disease
9%
Epidermal Growth Factor Receptor
7%
Gene Expression Profiling
7%
Hazard Ratio
5%
Lung Adenocarcinoma
11%
Lung Cancer
100%
Lung Cancer Survival
6%
Malignant Neoplasm
16%
Metastatic Carcinoma
5%
Neoplasm
20%
Nicotine Withdrawal
5%
Non Small Cell Lung Cancer
33%
Odds Ratio
5%
Overall Survival
12%
Pooled Analysis
5%
Prognostic Factor
8%
Proportional Hazards Model
5%
Quality of Life
20%
Recurrent Disease
6%
Single Nucleotide Polymorphism
5%
Small Cell Lung Cancer
9%
Smoking
19%
Squamous Cell Carcinoma
5%
Surgery
8%
Symptom
11%
Biochemistry, Genetics and Molecular Biology
Allele
13%
Cancer Cell
9%
Cancer Staging
7%
Cancer Survival
7%
Candidate Gene
7%
CHRNA5
5%
Cigarette Smoking
8%
Epidermal Growth Factor Receptor
10%
Gene Expression
6%
Gene Expression Profiling
8%
Genetic Divergence
6%
Genetic Variation
10%
Genetics
16%
Genome-Wide Association Study
13%
Genotyping
8%
Germ Cell
7%
Germline
7%
Glutathione
7%
Haplotype
8%
Messenger RNA
5%
Overall Survival
25%
Passive Smoking
7%
Single Nucleotide Polymorphism
7%
Single-Nucleotide Polymorphism
24%
Smoking
39%
Smoking Cessation
9%
